In order to provide better structure and purpose to the site I’ve decided to make some small-ish changes. From now on, posts will fall into two broad categories: Portfolio and General Investing. The latter will include the “Dividend Millionaire” articles which, unsurprisingly, are pretty popular. It will also include other tidbits and stories that focus on buy-and-hold type investing. You can find a link to them at the top of the homepage (or here), and at some point this week I will create a distinct category page for them.
The Compound Investor’s Dividend Portfolio
This will be the biggest change going forward. In response to queries, and also to provide some purpose to the single-stock focused articles, I will be writing about a select group of twenty dividend stocks. These are the companies that I hold directly, or will do in the next few months. By directly I mean via book entry form, not through stock brokers (e.g. DRS system in the United States, or good old fashioned stock certificates for the UK-listed names). In terms of disclosure you can therefore take it as a given that I am long these names. Starting at the end 1Q20 I’ll provide quarterly updates, and you can track it via the link on the homepage as well.
In terms of composition, you can find the details in the graphic below. As you can see, it is fairly conservative mega-cap (very much in the Buffett 20-slot punch card mould). Aside from that, there were only two parts to the selection criteria. First, and as mentioned above, these are the names I own (or will do so soon) via direct registration mechanisms (e.g. DRS system in the United States). Second, they are the companies I enjoy looking at and writing about the most (though there’s a few names I’ve yet to cover on here).
On that note, the caveats. First, this is not an exhaustive list of the best names in the world. Plenty of high quality blue-chips are not there. This is only representative of the stocks I own (or will do soon) in book entry form and enjoy keeping tabs on! So, if you are wondering why the likes of, say, Johnson & Johnson or Philip Morris aren’t there then that is why.
Ditto in terms of weightings, industry exposure, and so on. Don’t take this as something to be replicated (especially in equal-weighted terms) because, again, this list only represents stocks I own (or will do) via direct registration. As you can see, the valuation of this group as a block is not especially attractive at the moment. On that note, this is not endorsement of the prospects of any of individual constituent from today’s share prices.
If you enjoyed this article please hit the “heart” button below. This gives me a rough indication as to what kind of content is popular. If you would like to get new posts directly to your inbox, feel free to enter your email address in the sidebar and hit the “subscribe” button. Thank you for reading!